MAPT and supranuclear palsy, progressive, 1: NSF has been linked with PSP and Tau pathology because of an NSF exonic polymorphism within the MAPT H1 haplotype being associated with PSP, CBD, and FTD risk (Pastor et al., 2004; Yokoyama et al., 2017).